Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ0W0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,632
Award facts
- Contract value 100% obligated
- $14,632.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,632.34 by the Defense Logistics Agency on August 29, 2025, with an ultimate completion date of September 2, 2025. The contract, issued under firm fixed-price terms with no set-aside designation, covers the supply of Cosentyx (secukinumab) 300 mg pens in 2 ml formulations. This award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The Cosentyx delivery order fulfills the Defense Logistics Agency's pharmaceutical procurement needs for military medical supply chains. AmerisourceBergen's extensive federal contract portfolio with the DLA demonstrates the company's capability to meet competitive federal procurement requirements across a broad spectrum of therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The company's role as a prime vendor under the DLA Troop Support Medical contract enables it to supply critical pharmaceutical commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ0W0?
SPE2DB25FQ0W0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FQ0W0 worth?
The government has obligated $14,632 on SPE2DB25FQ0W0.
Is contract SPE2DB25FQ0W0 an order under another contract?
Yes. SPE2DB25FQ0W0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0W0 competed?
The extent of competition for SPE2DB25FQ0W0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award